Urticaria natural history, complications and prognosis: Difference between revisions
Jump to navigation
Jump to search
| (7 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Urticaria}} | {{Urticaria}} | ||
{{CMG}} | {{CMG}} ; {{AE}} {{Anahita}} | ||
==Overview== | ==Overview== | ||
[[Remission]] rate, [[Complication (medicine)|complications]] and [[prognosis]] of [[urticaria]] is tightly related to [[patient]] characteristic (such as age and gender), subtype of [[urticaria]] and concurrent [[angioedema]]. 10% to 60% of cases go into [[Remission (medicine)|remission]] within the first 5–10 years of [[disease]] [[diagnosis]]. Moreover [[treatments]] usually alleviate [[symptoms]] in most cases. Mean duration of [[urticaria]] presence is different among distinct sub-types. [[Urticaria]] [[patients]] are prone to some [[Complication (medicine)|complications]], such as [[infection|superimposed bacterial infection]], [[anaphylaxis]] and [[excoriation]] due to intense [[itch|pruritus]]. Most [[patient|patients]] improve over time, even stubborn cases. [[Prognosis]] and [[treatment]] response is better in [[patients]] younger than 19 years old, compared to older adults. [[Female|Female gender]], prolonged period of [[disease]] at the first visit, concurrent [[angioedema]], subtypes such as [[urticaria|physical urticaria]] and [[urticaria|cholinergic urticaria]] and chronic use of [[non-steroidal anti-inflammatory drug]] are related to worse [[prognosis]]. | |||
==Natural History, Complications, and Prognosis== | ==Natural History, Complications, and Prognosis== | ||
===Natural History=== | ===Natural History=== | ||
*Remission rate of [[urticaria|chronic urticaria]] has been estimated from 10% to 60% within the first 5–10 years of [[disease]] [[diagnosis]]. Moreover, data showed higher remission rate in [[patient|patients]] younger than 20 years old. <ref name="pmid28094108">{{cite journal| author=Tanaka T, Hiragun M, Hide M, Hiragun T| title=Analysis of primary treatment and prognosis of spontaneous urticaria. | journal=Allergol Int | year= 2017 | volume= 66 | issue= 3 | pages= 458-462 | pmid=28094108 | doi=10.1016/j.alit.2016.12.007 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28094108 }} </ref> | |||
*Most cases with [[urticaria|cholinergic urticaria]] have mild [[symptoms]] and 80% of [[ | *[[Remission (medicine)|Remission]] rate of [[urticaria|chronic urticaria]] has been estimated from 10% to 60% within the first 5–10 years of [[disease]] [[diagnosis]]. Moreover, data showed higher [[Remission (medicine)|remission]] rate in [[patient|patients]] younger than 20 years old. <ref name="pmid28094108">{{cite journal| author=Tanaka T, Hiragun M, Hide M, Hiragun T| title=Analysis of primary treatment and prognosis of spontaneous urticaria. | journal=Allergol Int | year= 2017 | volume= 66 | issue= 3 | pages= 458-462 | pmid=28094108 | doi=10.1016/j.alit.2016.12.007 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28094108 }} </ref> | ||
*Most cases with [[urticaria|cholinergic urticaria]] have mild [[symptoms]] and 80% of [[Patient|patient's]] don't seek [[medicine|medical]] attention. | |||
*The following table contains [[mean]] duration of some subtypes of [[urticaria]].<ref name="pmid14616095">{{cite journal| author=Zuberbier T| title=Urticaria. | journal=Allergy | year= 2003 | volume= 58 | issue= 12 | pages= 1224-34 | pmid=14616095 | doi=10.1046/j.1398-9995.2003.00327.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14616095 }} </ref> | *The following table contains [[mean]] duration of some subtypes of [[urticaria]].<ref name="pmid14616095">{{cite journal| author=Zuberbier T| title=Urticaria. | journal=Allergy | year= 2003 | volume= 58 | issue= 12 | pages= 1224-34 | pmid=14616095 | doi=10.1046/j.1398-9995.2003.00327.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14616095 }} </ref> | ||
{| border="1" cellpadding="3" | {| border="1" cellpadding="3" | ||
|- | |- | ||
|width="100pt"|Cold contact urticaria | | width="100pt" |[[urticaria|Cold contact urticaria]] | ||
|width="200pt"|4.2 years | | width="200pt" |4.2 years | ||
|- | |- | ||
|Delayed‐pressure urticaria || 6–9 years | |[[urticaria|Delayed‐pressure urticaria]]||6–9 years | ||
|- | |- | ||
|Dermographic urticaria || 6.5 years | |[[urticaria|Dermographic urticaria]]||6.5 years | ||
|} | |} | ||
===Complications=== | ===Complications=== | ||
Common [[Complication (medicine)|complications]] of [[urticaria]] include:<ref name="pmid14616095">{{cite journal| author=Zuberbier T| title=Urticaria. | journal=Allergy | year= 2003 | volume= 58 | issue= 12 | pages= 1224-34 | pmid=14616095 | doi=10.1046/j.1398-9995.2003.00327.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14616095 }} </ref><ref name="pmid15186377">{{cite journal| author=Valks R, Conde-Salazar L, Cuevas M| title=Allergic contact urticaria from natural rubber latex in healthcare and non-healthcare workers. | journal=Contact Dermatitis | year= 2004 | volume= 50 | issue= 4 | pages= 222-4 | pmid=15186377 | doi=10.1111/j.0105-1873.2004.00327.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15186377 }} </ref> | |||
*Superimposed [[infection|bacterial infection]] | |||
*[[Anaphylaxis]] | |||
*[[Excoriation]] due to intense [[itch|pruritus]] | |||
*[[urticaria|Pressure urticaria]] might turn into a debilitating [[disease]] in some occupations. | |||
===Prognosis=== | ===Prognosis=== | ||
*Most [[patient|patients]] improve over time, even stubborn cases.<ref name="pmid23205732">{{cite journal| author=Hiragun M, Hiragun T, Mihara S, Akita T, Tanaka J, Hide M| title=Prognosis of chronic spontaneous urticaria in 117 patients not controlled by a standard dose of antihistamine. | journal=Allergy | year= 2013 | volume= 68 | issue= 2 | pages= 229-35 | pmid=23205732 | doi=10.1111/all.12078 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23205732 }} </ref> | *Most [[patient|patients]] improve over time, even stubborn cases.<ref name="pmid23205732">{{cite journal| author=Hiragun M, Hiragun T, Mihara S, Akita T, Tanaka J, Hide M| title=Prognosis of chronic spontaneous urticaria in 117 patients not controlled by a standard dose of antihistamine. | journal=Allergy | year= 2013 | volume= 68 | issue= 2 | pages= 229-35 | pmid=23205732 | doi=10.1111/all.12078 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23205732 }} </ref> | ||
*[[Prognosis]] and [[treatment]] response is better in [[patients]] younger than 19 years old, compared to older adults.<ref name="pmid23205732">{{cite journal| author=Hiragun M, Hiragun T, Mihara S, Akita T, Tanaka J, Hide M| title=Prognosis of chronic spontaneous urticaria in 117 patients not controlled by a standard dose of antihistamine. | journal=Allergy | year= 2013 | volume= 68 | issue= 2 | pages= 229-35 | pmid=23205732 | doi=10.1111/all.12078 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23205732 }} </ref> | *[[Prognosis]] and [[treatment]] response is better in [[patients]] younger than 19 years old, compared to older adults.<ref name="pmid23205732">{{cite journal| author=Hiragun M, Hiragun T, Mihara S, Akita T, Tanaka J, Hide M| title=Prognosis of chronic spontaneous urticaria in 117 patients not controlled by a standard dose of antihistamine. | journal=Allergy | year= 2013 | volume= 68 | issue= 2 | pages= 229-35 | pmid=23205732 | doi=10.1111/all.12078 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23205732 }} </ref><ref name="pmid19706227">{{cite journal| author=Gregoriou S, Rigopoulos D, Katsambas A, Katsarou A, Papaioannou D, Gkouvi A | display-authors=etal| title=Etiologic aspects and prognostic factors of patients with chronic urticaria: nonrandomized, prospective, descriptive study. | journal=J Cutan Med Surg | year= 2009 | volume= 13 | issue= 4 | pages= 198-203 | pmid=19706227 | doi=10.2310/7750.2008.08035 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19706227 }} </ref> | ||
*The following are some factors related to worse [[urticaria]] [[prognosis]]:<ref name="pmid31571935">{{cite journal| author=Puxeddu I, Petrelli F, Angelotti F, Croia C, Migliorini P| title=Biomarkers In Chronic Spontaneous Urticaria: Current Targets And Clinical Implications. | journal=J Asthma Allergy | year= 2019 | volume= 12 | issue= | pages= 285-295 | pmid=31571935 | doi=10.2147/JAA.S184986 | pmc=6759208 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=31571935 }} </ref> | *The following are some factors related to worse [[urticaria]] [[prognosis]]:<ref name="pmid31571935">{{cite journal| author=Puxeddu I, Petrelli F, Angelotti F, Croia C, Migliorini P| title=Biomarkers In Chronic Spontaneous Urticaria: Current Targets And Clinical Implications. | journal=J Asthma Allergy | year= 2019 | volume= 12 | issue= | pages= 285-295 | pmid=31571935 | doi=10.2147/JAA.S184986 | pmc=6759208 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=31571935 }} </ref><ref name="pmid15230821">{{cite journal| author=Toubi E, Kessel A, Avshovich N, Bamberger E, Sabo E, Nusem D | display-authors=etal| title=Clinical and laboratory parameters in predicting chronic urticaria duration: a prospective study of 139 patients. | journal=Allergy | year= 2004 | volume= 59 | issue= 8 | pages= 869-73 | pmid=15230821 | doi=10.1111/j.1398-9995.2004.00473.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15230821 }} </ref><ref name="pmid30584542">{{cite journal| author=Folci M, Heffler E, Canonica GW, Furlan R, Brunetta E| title=Cutting Edge: Biomarkers for Chronic Spontaneous Urticaria. | journal=J Immunol Res | year= 2018 | volume= 2018 | issue= | pages= 5615109 | pmid=30584542 | doi=10.1155/2018/5615109 | pmc=6280255 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30584542 }} </ref><ref name="pmid14616095">{{cite journal| author=Zuberbier T| title=Urticaria. | journal=Allergy | year= 2003 | volume= 58 | issue= 12 | pages= 1224-34 | pmid=14616095 | doi=10.1046/j.1398-9995.2003.00327.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14616095 }} </ref><ref name="pmid10233318">{{cite journal| author=Poon E, Seed PT, Greaves MW, Kobza-Black A| title=The extent and nature of disability in different urticarial conditions. | journal=Br J Dermatol | year= 1999 | volume= 140 | issue= 4 | pages= 667-71 | pmid=10233318 | doi=10.1046/j.1365-2133.1999.02767.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10233318 }} </ref> | ||
**[[Female|Female gender]] | **[[Female|Female gender]] | ||
**Prolonged period of | **Prolonged period of [[disease]] at the first visit | ||
**Concurrent presentation of [[angioedema]] | **Concurrent presentation of [[angioedema]] | ||
**[[urticaria|Physical urticaria]] | **[[urticaria|Physical urticaria]], specially [[urticaria|delayed pressure urticaria]] | ||
**[[urticaria|Cholinergic urticaria]] | |||
**[[Non-steroidal anti-inflammatory drug]] use | |||
==References== | ==References== | ||
| Line 39: | Line 46: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Dermatology]] | [[Category:Dermatology]] | ||
[[Category:Allergology]] | [[Category:Allergology]] | ||
| Line 46: | Line 51: | ||
[[Category:Emergency medicine]] | [[Category:Emergency medicine]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
Latest revision as of 21:40, 29 January 2021
|
Urticaria Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Urticaria natural history, complications and prognosis On the Web |
|
American Roentgen Ray Society Images of Urticaria natural history, complications and prognosis |
|
FDA on Urticaria natural history, complications and prognosis |
|
CDC on Urticaria natural history, complications and prognosis |
|
Urticaria natural history, complications and prognosis in the news |
|
Blogs on Urticaria natural history, complications and prognosis |
|
Risk calculators and risk factors for Urticaria natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Anahita Deylamsalehi, M.D.[2]
Overview
Remission rate, complications and prognosis of urticaria is tightly related to patient characteristic (such as age and gender), subtype of urticaria and concurrent angioedema. 10% to 60% of cases go into remission within the first 5–10 years of disease diagnosis. Moreover treatments usually alleviate symptoms in most cases. Mean duration of urticaria presence is different among distinct sub-types. Urticaria patients are prone to some complications, such as superimposed bacterial infection, anaphylaxis and excoriation due to intense pruritus. Most patients improve over time, even stubborn cases. Prognosis and treatment response is better in patients younger than 19 years old, compared to older adults. Female gender, prolonged period of disease at the first visit, concurrent angioedema, subtypes such as physical urticaria and cholinergic urticaria and chronic use of non-steroidal anti-inflammatory drug are related to worse prognosis.
Natural History, Complications, and Prognosis
Natural History
- Remission rate of chronic urticaria has been estimated from 10% to 60% within the first 5–10 years of disease diagnosis. Moreover, data showed higher remission rate in patients younger than 20 years old. [1]
- Most cases with cholinergic urticaria have mild symptoms and 80% of patient's don't seek medical attention.
- The following table contains mean duration of some subtypes of urticaria.[2]
| Cold contact urticaria | 4.2 years |
| Delayed‐pressure urticaria | 6–9 years |
| Dermographic urticaria | 6.5 years |
Complications
Common complications of urticaria include:[2][3]
- Superimposed bacterial infection
- Anaphylaxis
- Excoriation due to intense pruritus
- Pressure urticaria might turn into a debilitating disease in some occupations.
Prognosis
- Most patients improve over time, even stubborn cases.[4]
- Prognosis and treatment response is better in patients younger than 19 years old, compared to older adults.[4][5]
- The following are some factors related to worse urticaria prognosis:[6][7][8][2][9]
- Female gender
- Prolonged period of disease at the first visit
- Concurrent presentation of angioedema
- Physical urticaria, specially delayed pressure urticaria
- Cholinergic urticaria
- Non-steroidal anti-inflammatory drug use
References
- ↑ Tanaka T, Hiragun M, Hide M, Hiragun T (2017). "Analysis of primary treatment and prognosis of spontaneous urticaria". Allergol Int. 66 (3): 458–462. doi:10.1016/j.alit.2016.12.007. PMID 28094108.
- ↑ 2.0 2.1 2.2 Zuberbier T (2003). "Urticaria". Allergy. 58 (12): 1224–34. doi:10.1046/j.1398-9995.2003.00327.x. PMID 14616095.
- ↑ Valks R, Conde-Salazar L, Cuevas M (2004). "Allergic contact urticaria from natural rubber latex in healthcare and non-healthcare workers". Contact Dermatitis. 50 (4): 222–4. doi:10.1111/j.0105-1873.2004.00327.x. PMID 15186377.
- ↑ 4.0 4.1 Hiragun M, Hiragun T, Mihara S, Akita T, Tanaka J, Hide M (2013). "Prognosis of chronic spontaneous urticaria in 117 patients not controlled by a standard dose of antihistamine". Allergy. 68 (2): 229–35. doi:10.1111/all.12078. PMID 23205732.
- ↑ Gregoriou S, Rigopoulos D, Katsambas A, Katsarou A, Papaioannou D, Gkouvi A; et al. (2009). "Etiologic aspects and prognostic factors of patients with chronic urticaria: nonrandomized, prospective, descriptive study". J Cutan Med Surg. 13 (4): 198–203. doi:10.2310/7750.2008.08035. PMID 19706227.
- ↑ Puxeddu I, Petrelli F, Angelotti F, Croia C, Migliorini P (2019). "Biomarkers In Chronic Spontaneous Urticaria: Current Targets And Clinical Implications". J Asthma Allergy. 12: 285–295. doi:10.2147/JAA.S184986. PMC 6759208 Check
|pmc=value (help). PMID 31571935. - ↑ Toubi E, Kessel A, Avshovich N, Bamberger E, Sabo E, Nusem D; et al. (2004). "Clinical and laboratory parameters in predicting chronic urticaria duration: a prospective study of 139 patients". Allergy. 59 (8): 869–73. doi:10.1111/j.1398-9995.2004.00473.x. PMID 15230821.
- ↑ Folci M, Heffler E, Canonica GW, Furlan R, Brunetta E (2018). "Cutting Edge: Biomarkers for Chronic Spontaneous Urticaria". J Immunol Res. 2018: 5615109. doi:10.1155/2018/5615109. PMC 6280255. PMID 30584542.
- ↑ Poon E, Seed PT, Greaves MW, Kobza-Black A (1999). "The extent and nature of disability in different urticarial conditions". Br J Dermatol. 140 (4): 667–71. doi:10.1046/j.1365-2133.1999.02767.x. PMID 10233318.